Skip to main content

US ClosedU.S. Closed

LSTA: Lisata Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies.

52W Range

17thpctl

Volume

1.24×avg

Market Cap

15.39MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Lisata Therapeutics, Inc.

LSTANASDAQ Capital Market·USD·Closed

Lisata Therapeutics, Inc.

LSTANASDAQ·USD·Closed

$1.69

−7.14%

$1.69

−$0.13 (7.14%)

52W Range

17thpctl

Volume

1.24×avg

Mkt Cap

15.39MUSD

P/E

-1.0TTM

Div Yield

–ann